News
- DexCom declined 3.5% to $72.33 despite the company reporting higher-than-expected quarterly earnings, but slower revenue growth weighed on the stock.
Oct 25, 2024 - Dexcom said revenue in the December quarter increased 17% to $815.2 million and net income rose to $91.8 million from $5.3 million and diluted EPS increased to 22 cents from 1 cents a year ago.
Feb 10, 2023
Links
Price
- Last Close
-
$ 77.73
-1.56 %
-1.24
Dec 6, 2024
- Trading Volume
- 75,418
- 52-Week High/Low
- $140 - $68
- Market Cap Full
- $ 26.9B
- YTD
- -100%
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 11.8% | 2.6% | -4.9% | -2.7% | -5% | -0.6% | 29.2% | 41.9% | -17.1% | - |
| Q2 | - | -0.9% | 10.6% | -85.5% | 18.6% | 4% | 27.1% | 27.4% | -13.7% | 16.8% | - |
| Q3 | - | - | -27.4% | 8.1% | 28.7% | 8% | -2.4% | 45.3% | -33.1% | 10.5% | - |
| Q4 | - | - | 31.2% | 40.6% | -1.7% | -10.3% | 47.5% | -10.4% | 15.6% | -31.9% | - |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -2.2% | -5.2% | 20.5% | -1.5% | - | - | - | - | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | -100% | -37% | 10% | -79% | 46% | 70% | 82% | 109% | -4% | -27% | 49% |
Earnings
| id | company_name | ticker | sector | industry | addresss | state | city | zip | country | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | ||||||||||
| Q2 | ||||||||||
| Q3 | ||||||||||
| Q4 | ||||||||||
| A |